Swisher Daniel N JR — SEC insider filings
SEC reporting owner CIK 1323113. 57 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers the 50 most recent of 57 filings on record, filed 2021-04-07 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 7,500 shares, $14,224 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 36 legs across 33 filings — 124,912 shares, $3,773,447 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 97.
- Largest priced transaction: sale of 15,385 shares @ $28.32 ($435,703) in CORCEPT THERAPEUTICS INC, filed 2022-08-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CORCEPT THERAPEUTICS INC (CORT) | Director | 35 | — | 33 legs · 94,535 sh · $3,615,356 | 75 |
| CERUS CORP (CERS) | Director | 10 | 2 legs · 7,500 sh · $14,224 | 3 legs · 30,377 sh · $158,091 | 15 |
| Jazz Pharmaceuticals plc (JAZZ) | President and COO | 4 | — | — | 6 |
| Protagonist Therapeutics, Inc (PTGX) | Director | 1 | — | — | 1 |
Insider filings — Swisher Daniel N JR
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 1,100 @ $14.08 · Option exercise (M): 400 @ $10.50 · Sale (S): 1,500 @ $74.07 · Option exercise (M): 1,100 (derivative) @ $0 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-10-15 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $14.08 · Sale (S): 2,200 @ $87.54 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2025-09-11 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $14.08 · Sale (S): 2,200 @ $72.45 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2025-08-12 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $14.08 · Sale (S): 2,200 @ $72.30 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2025-07-14 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $14.08 · Sale (S): 2,200 @ $71.08 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $14.08 · Sale (S): 2,200 @ $70.61 · Option exercise (M): 2,200 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-06-04 | 4 | CERUS CORP (CERS) | Grant/award (A): 60,000 @ $0 | EDGAR |
| 2025-05-14 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 1,800 @ $12.13 · Option exercise (M): 400 @ $14.08 · Sale (S): 1,800 @ $72.17 · Sale (S): 400 @ $71.55 · Option exercise (M): 1,800 (derivative) @ $0 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2025-04-14 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $12.13 · Sale (S): 2,200 @ $70.22 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $12.13 · Sale (S): 2,200 @ $53.60 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $12.13 · Sale (S): 2,200 @ $68.08 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2025-01-14 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $12.13 · Sale (S): 2,200 @ $50.54 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $12.13 · Sale (S): 2,200 @ $59.46 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2024-11-13 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $12.13 · Sale (S): 2,200 @ $59.88 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2024-08-05 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 150 @ $5.86 · Sale (S): 150 @ $38.50 · Option exercise (M): 150 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $5.86 · Sale (S): 2,200 @ $32.81 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | CERUS CORP (CERS) | Grant/award (A): 40,000 @ $5 | EDGAR |
| 2024-06-05 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $5.86 · Sale (S): 2,200 @ $30.21 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-05-09 | 4 | CERUS CORP (CERS) | Purchase (P): 2,500 @ $1.88 | EDGAR |
| 2024-05-03 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $5.86 · Sale (S): 2,200 @ $23.09 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $5.86 · Sale (S): 2,200 @ $25.30 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $5.86 · Sale (S): 2,200 @ $23.59 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $5.86 · Sale (S): 2,200 @ $22 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2024-01-04 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $5.86 · Sale (S): 2,200 @ $22.11 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2023-12-05 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $5.86 · Sale (S): 2,200 @ $25.47 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2023-11-03 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $5.86 · Sale (S): 2,200 @ $27.96 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2023-10-30 | 4 | Protagonist Therapeutics, Inc (PTGX) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2023-10-04 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $5.86 · Sale (S): 2,200 @ $27.32 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2023-09-06 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 1,550 @ $6.55 · Sale (S): 1,550 @ $32.73 · Option exercise (M): 2,200 @ $5.86 · Sale (S): 2,200 @ $32.90 · Option exercise (M): 1,550 (derivative) @ $0 · Option exercise (M): 2,200 (derivative) @ $0 | EDGAR |
| 2023-08-09 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 2,200 @ $6.55 · Option exercise (M): 650 @ $5.86 · Sale (S): 2,200 @ $30.14 · Sale (S): 650 @ $30.16 · Option exercise (M): 2,200 (derivative) @ $0 · Option exercise (M): 650 (derivative) @ $0 | EDGAR |
| 2023-06-09 | 4 | CERUS CORP (CERS) | Grant/award (A): 40,000 @ $5 | EDGAR |
| 2023-05-30 | 4 | CERUS CORP (CERS) | Purchase (P): 5,000 @ $1.91 | EDGAR |
| 2023-05-23 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2023-03-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 13,456 @ $0 · Tax withholding (F): 5,426 @ $142.78 | EDGAR |
| 2022-12-07 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Other (J): 10,465 @ $0 | EDGAR |
| 2022-11-14 | 4 | CERUS CORP (CERS) | Option exercise (M): 12,500 @ $3.19 · Sale (S): 12,500 @ $3.91 · Option exercise (M): 12,500 (derivative) | EDGAR |
| 2022-08-09 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 20,000 @ $6.55 · Tax withholding (F): 4,615 @ $28.39 · Sale (S): 15,385 @ $28.32 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2022-06-03 | 4 | CERUS CORP (CERS) | Grant/award (A): 20,454 @ $0 · Grant/award (A): 39,866 (derivative) | EDGAR |
| 2022-06-02 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2022-03-09 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Grant/award (A): 13,507 @ $0 · Tax withholding (F): 4,802 @ $153.96 | EDGAR |
| 2022-01-05 | 4 | Jazz Pharmaceuticals plc (JAZZ) | Tax withholding (F): 1,624 @ $131.01 | EDGAR |
| 2021-09-03 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 7,500 @ $6.55 · Sale (S): 7,500 @ $21.70 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2021-08-05 | 4 | CERUS CORP (CERS) | Option exercise (M): 12,877 @ $2.86 · Sale (S): 12,877 @ $6.25 · Option exercise (M): 12,877 (derivative) | EDGAR |
| 2021-06-04 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 7,500 @ $6.55 · Sale (S): 7,500 @ $21.48 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
| 2021-06-03 | 4 | CERUS CORP (CERS) | Option exercise (M): 15,961 · Grant/award (A): 17,525 @ $0 · Option exercise (M): 15,961 (derivative) · Grant/award (A): 35,295 (derivative) | EDGAR |
| 2021-05-28 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2021-05-20 | 4 | CERUS CORP (CERS) | Option exercise (M): 5,000 @ $2.90 · Sale (S): 5,000 @ $5.75 · Option exercise (M): 5,000 (derivative) | EDGAR |
| 2021-04-07 | 4 | CORCEPT THERAPEUTICS INC (CORT) | Option exercise (M): 7,500 @ $6.55 · Sale (S): 7,500 @ $24.14 · Option exercise (M): 7,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1323113 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs